Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

Science doesn't care about share price predictions.

NMDA antagonist. Patented for respiratory disease. Shown to decrease mortality >40% for acute lung injury and acute respiratory distress syndrome, same as COVID causes. Global demand, people dying around the world; people need a therapy now. Algernon has a safe one.

NMDA antagonist alters immune response, decrease neuronal hyperexcitability. Decrease glutamate excess. Save the neurons. Save the T cells. Save the pulmonary capillary endothelium. Save lives.

Better than the best big pharma has to offer.

Watch what happens when they get trial approval this week.

People like you always show up once penny's run. Love showing up trying to short. Can see right through it. Shorts will get wrecked upon the news drop. Could come any minute.